Implementation Guide CH VACD
5.0.0-ballot - ballot
This page is part of the CH VACD (R4) (v5.0.0-ballot: STU 5 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Generated Narrative: Immunization
ResourceImmunization "TCF01-IMMUN2"
Profile: CH VACD Immunization
Author of the content: Patient/TC-patient " WEGMUELLER"
CH VACD Extension Immunization Medication Reference: Medication/TC-IMMUN-MEDIC-HAVRIX1440
Entry Resource Cross References
url
entry
value:
urn:oid:2.16.756.5.30.1.402.1.3.1.1.1
/855bdd69-0a39-4241-b208-9b248a62fb76url
container
value: URI/urn:uuid:e2233a2f-d1c2-459d-b4fe-4920c35339e7
url
relationcode
value: replaces
identifier: urn:oid:2.16.756.5.30.1.402.1.3.1.1.1
/e2233a2f-d1c2-459d-b4fe-4920c35339e7
status: completed
vaccineCode: Havrix 1440 (CH VACD Swissmedic Authorized Vaccines#558)
patient: Patient/TC-patient " WEGMUELLER"
occurrence: 2021-05-27
recorded: 2021-05-27 00:00:00+0200
lotNumber: AHAVB946A
route: Intramuscular use (standardterms.edqm.eu#20035000)
Actor |
PractitionerRole/TC-HCP1-ORG1-ROLE-performer |
note: Der Patient hat diese Impfung ohne jegliche Nebenwirkungen gut vertragen. (By Practitioner/TC-HCP1-C1 @2021-06-02)
TargetDisease | DoseNumber[x] |
Viral hepatitis, type A (disorder) (SNOWMED CT#40468003) | 1 |